Literature DB >> 17215794

Chronic obstructive pulmonary disease and sleep: the interaction.

F Urbano1, V Mohsenin.   

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death, affecting 14 millions adults in the United States. Symptoms related to sleep disturbances are common in individuals with moderate to severe COPD, particularly in the elderly, which is commonly manifested as morning fatigue and early awakenings. One major cause of morbidity in this population is abnormalities in gas exchange and resultant hypoxemia as they can lead to elevated pulmonary pressures, dyspnea and in severe cases right ventricular overload and failure. Sleep has profound adverse effects on respiration and gas exchange in patients with COPD. There are several mechanisms underlying nonapneic oxygen desaturation during sleep. They include decreased functional residual capacity, diminished ventilatory responses to hypoxia and hypercapnia, impaired respiratory mechanics, diminished arousal, respiratory muscle fatigue, diminished nonchemical respiratory drive, increased upper airway resistance, and the starting point of baseline saturation values while awake on the oxyhemoglobin dissociation curve. Smoking cessation, bronchodilation, inhaled steroids in those with a reversible component and pulmonary rehabilitation are corner stones of treatment of COPD. The goals of therapy for the clinician should be to improve lung mechanics as well as gas exchange ultimately leading to better sleep quality and health status.

Entities:  

Mesh:

Year:  2006        PMID: 17215794

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  7 in total

1.  The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.

Authors:  Su-Jung Chen; Chiu-Mei Yeh; Tze-Fan Chao; Chia-Jen Liu; Kang-Ling Wang; Tzeng-Ji Chen; Pesus Chou; Fu-Der Wang
Journal:  Sleep       Date:  2015-07-01       Impact factor: 5.849

2.  The effects of depression, anxiety and sleep disturbances on cognitive impairment in patients with chronic obstructive pulmonary disease.

Authors:  Yesim Güzey Aras; Abdülkadir Tunç; Belma Doğan Güngen; Adil Can Güngen; Yusuf Aydemir; Bekir Enes Demiyürek
Journal:  Cogn Neurodyn       Date:  2017-08-05       Impact factor: 5.082

Review 3.  Sleep disturbances and fatigue in critically ill patients.

Authors:  Ellyn E Matthews
Journal:  AACN Adv Crit Care       Date:  2011 Jul-Sep

4.  Acrolein inhalation alters arterial blood gases and triggers carotid body-mediated cardiovascular responses in hypertensive rats.

Authors:  Christina M Perez; Mehdi S Hazari; Allen D Ledbetter; Najwa Haykal-Coates; Alex P Carll; Wayne E Cascio; Darrell W Winsett; Daniel L Costa; Aimen K Farraj
Journal:  Inhal Toxicol       Date:  2015-01       Impact factor: 2.724

5.  Integrated management strategies for chronic obstructive pulmonary disease.

Authors:  David A Sonetti; Angela C Hospenthal; Sandra G Adams
Journal:  J Multidiscip Healthc       Date:  2010-09-20

Review 6.  Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD.

Authors:  Daniel R Ouellette; Kim L Lavoie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-16

7.  The effect of benzodiazepines on insomnia in patients with chronic obstructive pulmonary disease: a meta-analysis of treatment efficacy and safety.

Authors:  Xiao-Min Lu; Ji-Ping Zhu; Xian-Mei Zhou
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.